2,3-dichloropyridine
Reaction #719
수율 10.8%750 AstraZeneca ELN dataset
Reaction #47902
desired compound
수율 25.6%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2010_06
Reaction #47905
desired compound
수율 30.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2010_06
Reaction #47908
desired compound
수율 28.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2010_06
Reaction #47912
desired compound
수율 19.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2010_06
Reaction #47928
desired compound
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2010_06
Reaction #47935
desired compound
수율 26.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2010_06
Reaction #74263
2-(3-bromo-1H-pyrazol-1-yl)-3-chloropyridine
수율 68.5%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_09
Reaction #90213
desired intermediate
수율 75.1%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2016_09
Reaction #90217
title product
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2016_09
Reaction #90222
pink solid
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2016_09
Reaction #179088
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
Reaction #184885
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
Reaction #193926
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
Reaction #210766
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
Reaction #223216
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
Reaction #225863
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
Reaction #227190
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
Reaction #230894
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
Reaction #240659
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
1 페이지다음 페이지